{Reference Type}: Journal Article
{Title}: Regulation of the human thioredoxin gene promoter and its key substrates: a study of functional and putative regulatory elements.
{Author}: Hawkes HJ;Karlenius TC;Tonissen KF;
{Journal}: Biochim Biophys Acta
{Volume}: 1840
{Issue}: 1
{Year}: Jan 2014
暂无{DOI}: 10.1016/j.bbagen.2013.09.013
{Abstract}: <B>BACKGROUND: </B>The thioredoxin system maintains redox balance through the action of thioredoxin and thioredoxin reductase. Thioredoxin regulates the activity of various substrates, including those that function to counteract cellular oxidative stress. These include the peroxiredoxins, methionine sulfoxide reductase A and specific transcription factors. Of particular relevance is Redox Factor-1, which in turn activates other redox-regulated transcription factors.<BR><B>METHODS: </B>Experimentally defined transcription factor binding sites in the human thioredoxin and thioredoxin reductase gene promoters together with promoters of the major thioredoxin system substrates involved in regulating cellular redox status are discussed. An in silico approach was used to identify potential putative binding sites for these transcription factors in all of these promoters.<BR><B>CONCLUSIONS: </B>Our analysis reveals that many redox gene promoters contain the same transcription factor binding sites. Several of these transcription factors are in turn redox regulated. The ARE is present in several of these promoters and is bound by Nrf2 during various oxidative stress stimuli to upregulate gene expression. Other transcription factors also bind to these promoters during the same oxidative stress stimuli, with this redundancy supporting the importance of the antioxidant response. Putative transcription factor sites were identified in silico, which in combination with specific regulatory knowledge for that gene promoter may inform future experiments.<BR><B>CONCLUSIONS: </B>Redox proteins are involved in many cellular signalling pathways and aberrant expression can lead to disease or other pathological conditions. Therefore understanding how their expression is regulated is relevant for developing therapeutic agents that target these pathways.